Sunday - February 1, 2026
GSK's Shingrix Prefilled Syringe Presentation Approved by the European Commission
January 07, 2026
LONDON, England, Jan. 7 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release:

* * *

GSK's Shingrix (Recombinant Zoster Vaccine) prefilled syringe presentation approved by the European Commission

* Prefilled syringe offers healthcare professionals a convenient administration option

* New presentation will begin rolling out across EU countries in 2026

* Shingles affects approximately . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products